Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
Crossref DOI link: https://doi.org/10.1007/s40744-018-0117-3
Published Online: 2018-06-01
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nash, Peter
McInnes, Iain B.
Mease, Philip J.
Thom, Howard
Hunger, Matthias
Karabis, Andreas
Gandhi, Kunal
Mpofu, Shephard
Jugl, Steffen M.
Article History
First Online: 1 June 2018